News

Researchers at RIT are developing technology that will be able to determine the lifespan of a heart valve with more precision.

The Science Times highlights the influential role of Tejas Padliya '16 (computer science) in leveraging AI to revolutionize healthcare, combining technical expertise with a compassionate approach to improve patient outcomes, address societal challenges, and promote accessibility.

Knowing that many doctors question the accuracy of automatic blood pressure cuffs led Aidan Hughes to pitch his idea to make a more accurate prototype.

An engineering researcher at RIT has discovered the means to process data using DNA. Amlan Ganguly, computer engineering department head in RIT’s Kate Gleason College of Engineering, and researchers at the University of Minnesota, designed a microfluidic integrated circuit to perform complex operations through artificial neural network computations on data stored in DNA.

In tumors, cells follow microscopic fibers, comparable to following roads through a city. Researchers at Rochester Institute of Technology developed a new technique to study different features of these “fiber highways” to provide new insights into how cells move efficiently through the tumor environment.

Emiliano Brini, assistant professor in the School of Chemistry and Materials Science, has received an award from the National Institutes of Health to support his research on building the next generation of drugs. Brini and his team of students will develop computational tools that can predict the strength of the interaction between two proteins and how drugs will modify this interaction.

The Rochester Business Journal features the Human Movement Lab and talks to Jason Rich, lecturer in the exercise science program. (This content may require a subscription to view.)

RIT reached another record year in sponsored research awards, attaining more than $94 million in fiscal year 2022-2023. Some key areas of research include nanotechnology, optics and imaging science, cybersecurity and artificial intelligence, and growth in life sciences and health fields.

For nearly a decade, RIT audiologist Catherine Clark has been volunteering in Ethiopia, providing essential services to the country’s deaf and hard-of-hearing children. As a result of her efforts, Clark was recognized recently with the naming of a new audiology lab in her honor.

Researchers are improving non-invasive treatment options for degenerative disc disease, an ailment that impacts 3 million adults yearly in the U.S. Using state-of-the-art gene editing technology in mesenchymal stem cells, the researchers will add to the growing field of regenerative medicine, the process of producing cellular therapies to alleviate pain and lack of mobility.

Researchers from RIT and University of Washington are harnessing the power of interactive media and clinical hypnosis to help people manage pain without drugs. The team has received a National Institutes of Health (NIH) grant for the work.

PharmaVoice talks to David Longo ’10 (computational mathematics), CEO of drug design company Ordaos, about artificial intelligence in drug development.